Logo image of PORF.AS

PORCELEYNE FLES (PORF.AS) Stock Earnings Estimates

Europe - Euronext Amsterdam - AMS:PORF - NL0000378669 - Common Stock

11.8 EUR
-0.1 (-0.84%)
Last: 1/23/2026, 7:00:00 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024
Revenue
YoY % growth
PORF.AS revenue by date.PORF.AS revenue by date.
7.1M
43.84%
8.398M
18.28%
8.721M
3.85%
EBITDA
YoY % growth
PORF.AS ebitda by date.PORF.AS ebitda by date.
2.063M
43.36%
1.766M
-14.40%
1.345M
-23.84%
EBIT
YoY % growth
PORF.AS ebit by date.PORF.AS ebit by date.
1.532M
68.17%
1.169M
-23.69%
767K
-34.39%
Operating Margin
PORF.AS operating margin by date.PORF.AS operating margin by date.
21.58%13.92%8.79%
EPS
YoY % growth
PORF.AS eps by date.PORF.AS eps by date.
N/AN/AN/A

All data in EUR

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in EUR

Recent Earnings VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Recent Revenue VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
4.859M
8.12%
%
Q4 2024
Q2Q % growth
4.227M
0.28%
%
Q2 2024
Q2Q % growth
4.494M
7.43%
%
Q4 2023
Q2Q % growth
4.215M
11.51%
%
Q2 2023
Q2Q % growth
4.183M
25.99%
%
Q4 2022
Q2Q % growth
3.78M
34.52%
%
Q2 2022
Q2Q % growth
3.32M
56.16%
%
Q4 2021
Q2Q % growth
2.81M
96.09%
%
Q2 2021
Q2Q % growth
2.126M
-14.07%
%
PORF.AS Yearly Revenue VS EstimatesPORF.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A